Assessing The Value Of Post-Approval Research For U.S. Policy Makers Dan CrippenandKirsten Axelsen July 29, 2026

https://www.healthaffairs.org/content/forefront/research-agenda-assess-value-post-approval-drug-research-us-policy-makers?utm_campaign=forefront&utm_medium=email&_hsenc=p2ANqtz-_FCqOr2kF_ta9ahMTd5ILrFUwTVgNYGbls_jGE-t9r2PNwR3SdlRTBmr64ju01JDSnfS20doofvh_PJsJDsiZK8e4aVA&_hsmi=431087348&utm_source=hasu Understanding the impact of price controls on drug research and approvals of secondary indications is critical for policy makers considering the expansion of price setting within and beyond the Inflation Reduction Act.